secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nexentis Technologies Inc. (NXTS)
CIK:        0001789192
Form:       8-K
Filed at:   2024-12-26T23:59:59+00:00
Accession:  0001493152-24-051967
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

N2OFF loans $250K to MitoCareX; issues 650K shares to directors
---------------------------------------------------------------

- Loaned $250,000 to MitoCareX Bio Ltd. at Israel Tax Authority rate + 3%, due in six months.
- Loan guaranteed by L.I.A. Pure Capital Ltd. If MitoCareX becomes a subsidiary, outstanding amount deducted from future allocations.
- Issued 650,000 common shares to directors under 2022 Share Incentive Plan on December 23, 2024.
- Board and compensation committee recommended issuance; non-binding stockholder approval received November 13, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1789192/000149315224051967/0001493152-24-051967-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1789192/000149315224051967/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-051967

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer